150 related articles for article (PubMed ID: 23642012)
1. Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends.
Lafrance JP; Cardinal H; Leblanc M; Madore F; Pichette V; Roy L; Le Lorier J
BMC Nephrol; 2013 May; 14():100. PubMed ID: 23642012
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
Schumock GT; Walton SM; Lee TA; Marx SE; Audhya P; Andress DL
Nephron Clin Pract; 2011; 117(2):c151-9. PubMed ID: 20699620
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
[TBL] [Abstract][Full Text] [Related]
4. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
[TBL] [Abstract][Full Text] [Related]
5. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
6. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of cinacalcet withdrawal in Australian dialysis patients.
Ruderman I; Holt SG; Kirkland GS; Maslen S; Hawley CM; Oliver V; Krishnasamy R; Gray NA; Talaulikar GS; Nelson CL; Rajaram Y; Gock H; Au E; Elder GJ; Mainra R; Toussaint ND
Intern Med J; 2019 Jan; 49(1):48-54. PubMed ID: 29992701
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
Lomonte C; Antonelli M; Losurdo N; Marchio G; Giammaria B; Basile C
Nephrol Dial Transplant; 2007 Jul; 22(7):2056-62. PubMed ID: 17449495
[TBL] [Abstract][Full Text] [Related]
11. The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy.
Somnay YR; Weinlander E; Schneider DF; Sippel RS; Chen H
Surgery; 2014 Dec; 156(6):1308-13; discussion 1313-4. PubMed ID: 25456900
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics.
van der Plas WY; Engelsman AF; Umakanthan M; Mather A; Sidhu SB; Delbridge LW; Pollock C; Waugh D; Sywak MS; Kruijff S
Surgery; 2019 Jan; 165(1):135-141. PubMed ID: 30413324
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.
Baker D; Sevak S; Callahan RE; Czako PF; Lloyd LR; Nagar S
Am J Surg; 2019 Jan; 217(1):146-151. PubMed ID: 29929906
[TBL] [Abstract][Full Text] [Related]
14. Surgical parathyroidectomy versus cinacalcet therapy: in the management of secondary hyperparathyroidism.
Ghani A; Baxter P
Otolaryngol Head Neck Surg; 2012 Feb; 146(2):220-5. PubMed ID: 22075073
[TBL] [Abstract][Full Text] [Related]
15. Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
Kim SM; Long J; Montez-Rath ME; Leonard MB; Norton JA; Chertow GM
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1260-1267. PubMed ID: 27269300
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.
Tominaga Y; Kakuta T; Yasunaga C; Nakamura M; Kadokura Y; Tahara H
Ther Apher Dial; 2016 Feb; 20(1):6-11. PubMed ID: 26879490
[TBL] [Abstract][Full Text] [Related]
17. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
[TBL] [Abstract][Full Text] [Related]
18. A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet.
Oshiro Y; Tanaka H; Okimoto N
Clin Exp Nephrol; 2011 Aug; 15(4):607-10. PubMed ID: 21455660
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy.
Eandi M; Pradelli L; Iannazzo S; Chiroli S; Pontoriero G
Pharmacoeconomics; 2010; 28(11):1041-54. PubMed ID: 20936886
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
